COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
The Penco Module Advances to the Next Stage of Its Permitting Process
Aclara Resources Inc. announces progress in the evaluation process of Penco Module's Environmental Impact Assessment, with reduced observations received and commitment to sustainable rare earth extraction practices -
COMMUNIQUÉ DE PRESSE
Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05
Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing -
-
-
-
COMMUNIQUÉ DE PRESSE
NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387 - A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections
NanoViricides, Inc. provides update on Phase II clinical trial plans for broad-spectrum antiviral drug candidate NV-387 against RSV, COVID, and Influenza. Potential $12 Billion market. Novel trial design expected -
COMMUNIQUÉ DE PRESSE
SXG Extends High-Grade Mineralisation 150 m Down Dip at Rising Sun West
Mawson Gold Limited reports high-grade gold and antimony intersections at Sunday Creek Project in Victoria, Australia. Assay results from drill holes SDDSC122 and SDDSC122W1 revealed significant mineralization -
-
